Abstract

Purpose: To evaluate the impact of individualized magnitude and phase signal arterial input function (AIF) measurements as well as voxel-based pre-contrast T10 relaxation on tumour perfusion metrics from DCE-MRI compared to DCE-CT using a common 4D temporal dynamic analysis (TDA) method. Methods: Nine patients with 13 brain metastases underwent volumetric DCE-CT (Toshiba, Aquilion ONE) and DCE-MRI (IMRIS 3T Verio) at baseline then 7 and 21 days post-radiosurgery. Voxel-based whole brain TDA was performed on all data using in-house software producing kinetic parameters AUC, Ktrans, Kep, and Vb (using the Modified Tofts model). AIF susceptibility was investigated in DCE-CT by selecting the AIF (from internal carotid artery) or VIF (from Sagittal Sinus). In DCE-MRI an individual Magnitude or Phase-based AIF (Sagittal Sinus) was compared to population-based AIF together with susceptibility to voxel-based T10 maps instead of a constant of 2400 msec. Absolute DCE-MRI values were compared to DCE-CT by Pearson correlation. Results: No significant difference in median Ktrans (0.048 +/−0.03 s-1) or AUC (2785.5 +/−1143.6 HU.s) was found between individual AIF and VIF-based DCE CT analyses. Using individual Magnitude VIF or Phase-based AIF for DCE-MRI (T10 2400 ms) resulted in higher Ktrans values (0.181 +/−0.11 vs. 0.121 +/−0.099 s-1). This is likely resulting from the smaller AIF peak since the population AIF (which more closely resembles CT) correlates better to DCE-CT metrics. Using voxel-based T10 maps caused further statistically-significant increase in Ktrans and AUC (p<0.0006) that could be contributed to a lower median T10 value (1572 +/−594, n=41). Conclusion: This preliminary data highlights the stability of DCE-CT calculations as well as susceptibility of DCE-MRI Ktrans measurements to various imaging factors, including AIF selection and T10 values used for modeling. Efforts to improve voxel-based T10 map calculations are being explored to further explain discrepancies between analysis methods. Brain Tumor Foundation of Canada and Ontario Institute of Cancer Research

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call